Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Golden Pharmatech is a leading Chinese Contract Research Organization (CRO) that provides comprehensive clinical research services to the global pharmaceutical and biotechnology industries. Founded in 2006 and headquartered in Shanghai, the company specializes in clinical trial management, regulatory affairs, site management (SMO), and data management. They offer end-to-end support for drug and medical device development, with a particular focus on navigating the NMPA regulatory pathway in China. The firm has extensive experience across multiple therapeutic areas, including oncology, cardiovascular disease, and endocrinology. Shanghai Golden Pharmatech operates several offices across China and maintains a presence in the United States to support international multi-center clinical trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Golden Pharmatech.